CARMA1-mediated NF-κB and JNK activation in lymphocytes

Immunological Reviews

Volumn 228, Issue 1, 2009, Pages 199-211

  Blonska, Marzenna ^a   Lin, Xin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

AP 1; CARMA1; IKK; JNK; Jun; NF B

Indexed keywords

ACTIVATED PROTEIN C; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; GUANYLATE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; PHOSPHOTRANSFERASE; SCAFFOLD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPSIN I; TRANSCRIPTION FACTOR;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL DEGENERATION; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MOTION; DEREGULATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MUCOSA; PRIORITY JOURNAL; REGULATORY MECHANISM; STEM CELL; T LYMPHOCYTE;

ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE 4; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 61849113179     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00749.x     Document Type: Article

References (119)

1. Samelson LE. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu Rev Immunol 2002 20 : 371 394.
2. Clements JL, Boerth NJ, Lee JR, Koretzky GA. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol 1999 17 : 89 108.
3. Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor kappa B. Immunity 2006 25 : 701 715.
4. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002 3 : 221 227.
5. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000 18 : 621 663.
6. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008 132 : 344 362.
7. Wang D, et al. A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 2002 3 : 830 835.
8. Wang D, et al. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol 2004 24 : 164 171.
9. Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J Biol Chem 2004 279 : 15870 15876.
10. Matsumoto R, et al. Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-kappaB activation. Immunity 2005 23 : 575 585.
11. Shambharkar PB, et al. Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. EMBO J 2007 26 : 1794 1805.
12. Tanner MJ, Hanel W, Gaffen SL, Lin X. CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J Biol Chem 2007 282 : 17141 17147.
13. Blonska M, et al. The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 2007 26 : 55 66.
14. Dustin ML, et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998 94 : 667 677.
15. Xavier R, Seed B. Membrane compartmentation and the response to antigen. Curr Opin Immunol 1999 11 : 265 269.
16. Bromley SK, et al. The immunological synapse. Annu Rev Immunol 2001 19 : 375 396.
17. Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-theta during T-cell activation. Nature 1997 385 : 83 86.
18. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol Cell Biol 2000 20 : 2933 2940.
19. Coudronniere N, Villalba M, Englund N, Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci USA 2000 97 : 3394 3399.
20. Sun Z, et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000 404 : 402 407.
21. Gaide O, et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002 3 : 836 843.
22. Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J 2002 21 : 5184 5194.
23. Hara H, et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003 18 : 763 775.
24. Egawa T, et al. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol 2003 13 : 1252 1258.
25. Newton K, Dixit V. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr Biol 2003 13 : 1247 1251.
26. Jun J, et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003 18 : 751 762.
27. Pappu BP, Lin X. Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation. Eur J Immunol 2006 36 : 3033 3043.
28. Bertin J, et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 2001 276 : 11877 11882.
29. Gaide O, Martinon F, Micheau O, Bonnet D, Thome M, Tschopp J. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett 2001 496 : 121 127.
30. Dimitratos SD, Woods DF, Stathakis DG, Bryant PJ. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 1999 21 : 912 921.
31. Wang L, et al. Card10 is a novel caspase recruitment domain/membrane- associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem 2001 276 : 21405 21409.
32. McAllister-Lucas LM, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 2001 276 : 30589 30597.
33. Grabiner BC, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF- kappa B activation. Genes Dev 2007 21 : 984 996.
34. Hara H, et al. The molecular adapter Carma1 controls entry of IkappaB kinase into the central immune synapse. J Exp Med 2004 200 : 1167 1177.
35. Willis TG, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999 96 : 35 45.
36. Zhang Q, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999 22 : 63 68.
37. Koseki T, et al. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem 1999 274 : 9955 9961.
38. Thome M, et al. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem 1999 274 : 9962 9968.
39. Yan M, Lee J, Schilbach S, Goddard A, Dixit V. mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem 1999 274 : 10287 10292.
40. Ruland J, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 2001 104 : 33 42.
41. Dierlamm J, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999 93 : 3601 3609.
42. Akagi T, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999 18 : 5785 5794.
43. Uren AG, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000 6 : 961 967.
44. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 2003 302 : 1581 1584.
45. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003 19 : 749 758.
46. Ferch U, et al. MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat Immunol 2007 8 : 984 991.
47. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 2005 308 : 114 118.
48. Medeiros RB, et al. Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 2007 316 : 754 758.
49. Su TT, et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 2002 3 : 780 786.
50. Saijo K, Mecklenbrauker I, Schmedt C, Tarakhovsky A. B cell immunity regulated by the protein kinase C family. Ann N Y Acad Sci 2003 987 : 125 134.
51. Sommer K, et al. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity 2005 23 : 561 574.
52. Shinohara H, et al. PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J Exp Med 2005 202 : 1423 1431.
53. Shinohara H, Maeda S, Watarai H, Kurosaki T. IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. J Exp Med 2007 204 : 3285 3293.
54. Narayan P, Holt B, Tosti R, Kane LP. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol Cell Biol 2006 26 : 2327 2336.
55. Qiao G, et al. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol 2008 28 : 2470 2480.
56. McCully RR, Pomerantz JL. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. Mol Cell Biol 2008 28 : 5668 5686.
57. Ishiguro K, et al. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation. Mol Cell Biol 2006 26 : 5497 5508.
58. Schaefer BC, Kappler JW, Kupfer A, Marrack P. Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation. Proc Natl Acad Sci USA 2004 101 : 1004 1009.
59. Rossman JS, Stoicheva NG, Langel FD, Patterson GH, Lippincott-Schwartz J, Schaefer BC. POLKADOTS are foci of functional interactions in T-Cell receptor-mediated signaling to NF-kappaB. Mol Biol Cell 2006 17 : 2166 2176.
60. Wu CJ, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci USA 2008 105 : 3023 3028.
61. Ruefli-Brasse AA, Lee WP, Hurst S, Dixit VM. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J Biol Chem 2004 279 : 1570 1574.
62. Wegener E, et al. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol Cell 2006 23 : 13 23.
63. Ishiguro K, Ando T, Goto H, Xavier R. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol Immunol 2007 44 : 2095 2100.
64. Zeng H, et al. Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. Mol Cell Biol 2007 27 : 5235 5245.
65. Lobry C, Lopez T, Israel A, Weil R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 2007 104 : 908 913.
66. Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol 2004 24 : 3860 3873.
67. Zhou H, et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 2004 427 : 167 171.
68. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004 14 : 289 301.
69. Oeckinghaus A, et al. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 2007 26 : 4634 4645.
70. Rebeaud F, et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 2008 9 : 272 281.
71. Coornaert B, et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 2008 9 : 263 271.
72. Kawadler H, Gantz MA, Riley JL, Yang X. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 2008 31 : 415 421.
73. Su H, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005 307 : 1465 1468.
74. King CG, et al. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med 2006 12 : 1088 1092.
75. Ni CY, et al. Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J Immunol 2008 180 : 7107 7111.
76. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999 284 : 309 313.
77. Ling L, Cao Z, Goeddel DV. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc Natl Acad Sci USA 1998 95 : 3792 3797.
78. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999 398 : 252 256.
79. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001 412 : 346 351.
80. Sato S, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005 6 : 1087 1095.
81. Shim JH, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005 19 : 2668 2681.
82. Liu HH, Xie M, Schneider MD, Chen ZJ. Essential role of TAK1 in thymocyte development and activation. Proc Natl Acad Sci USA 2006 103 : 11677 11682.
83. Sato S, et al. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int Immunol 2006 18 : 1405 1411.
84. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 2006 7 : 851 858.
85. Chang L, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006 124 : 601 613.
86. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994 77 : 727 736.
87. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002 20 : 55 72.
88. Gupta S, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996 15 : 2760 2770.
89. Kallunki T, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994 8 : 2996 3007.
90. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. Defective T cell differentiation in the absence of Jnk1. Science 1998 282 : 2092 2095.
91. Dong C, et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 2000 405 : 91 94.
92. Yang DD, et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 1998 9 : 575 585.
93. Weiss L, Whitmarsh AJ, Yang DD, Rincon M, Davis RJ, Flavell RA. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation. J Exp Med 2000 191 : 139 146.
94. Fuchs SY, Dolan L, Davis RJ, Ronai Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 1996 13 : 1531 1535.
95. Fuchs SY, Xie B, Adler V, Fried VA, Davis RJ, Ronai Z. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J Biol Chem 1997 272 : 32163 32168.
96. Derijard B, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994 76 : 1025 1037.
97. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000 103 : 239 252.
98. Cuevas BD, Abell AN, Johnson GL. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007 26 : 3159 3171.
99. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002 4 : E131 E136.
100. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003 3 : 859 868.
101. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001 20 : 2390 2400.
102. Mathas S, et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 2002 21 : 4104 4113.
103. Troen G, et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn 2004 6 : 297 307.
104. Leventaki V, et al. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood 2007 110 : 1621 1630.
105. Chauhan D, et al. Regulation of c-jun gene expression in human T lymphocytes. Blood 1993 81 : 1540 1548.
106. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 1988 55 : 875 885.
107. Laine A, Ronai Z. Ubiquitin chains in the ladder of MAPK signaling. Sci STKE 2005 2005 : re5.
108. Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 2004 15 : 713 725.
109. Musti AM, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 1997 275 : 400 402.
110. Sabapathy K, Wagner EF. JNK2: a negative regulator of cellular proliferation. Cell Cycle 2004 3 : 1520 1523.
111. Gao M, et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004 306 : 271 275.
112. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008 8 : 83 93.
113. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 2003 11 : 1479 1489.
114. Yazgan O, Pfarr CM. Regulation of two JunD isoforms by Jun N-terminal kinases. J Biol Chem 2002 277 : 29710 29718.
115. Chen J, Stewart V, Spyrou G, Hilberg F, Wagner EF, Alt FW. Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. Immunity 1994 1 : 65 72.
116. Oshiro A, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006 107 : 4500 4507.
117. Nakamura S, et al. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma. Cancer 2005 104 : 1885 1893.
118. Ngo VN, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006 441 : 106 110.
119. Lenz G, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008 319 : 1676 1679.